HLA-DRB1 and autoimmune hepatitis: Moreover, the high risk for autoimmune liver disease advocates special attention to CeD patients with genetic predispositions to this condition (e.g., genetic risk alleles at HLA-DRB1),12 and screening for related autoantibodies might be considered in case of cryptogenic hypertransaminasemia.5